Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

InMed Pharmaceuticals (INM) Other Gross PP&E Adjustments (2021 - 2025)

InMed Pharmaceuticals (INM) has 5 years of Other Gross PP&E Adjustments data on record, last reported at $2.3 million in Q2 2025.

  • For Q2 2025, Other Gross PP&E Adjustments fell 10.55% year-over-year to $2.3 million; the TTM value through Jun 2025 reached $2.3 million, down 10.55%, while the annual FY2025 figure was $2.3 million, 10.55% down from the prior year.
  • Other Gross PP&E Adjustments reached $2.3 million in Q2 2025 per INM's latest filing, roughly flat from $2.3 million in the prior quarter.
  • Across five years, Other Gross PP&E Adjustments topped out at $2.6 million in Q4 2023 and bottomed at $549195.0 in Q3 2021.
  • Average Other Gross PP&E Adjustments over 5 years is $1.9 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Other Gross PP&E Adjustments: skyrocketed 158.69% in 2022, then decreased 10.95% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at $1.4 million in 2021, then grew by 0.25% to $1.4 million in 2022, then skyrocketed by 83.38% to $2.6 million in 2023, then decreased by 8.99% to $2.4 million in 2024, then decreased by 1.71% to $2.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Gross PP&E Adjustments were $2.3 million in Q2 2025, $2.3 million in Q1 2025, and $2.4 million in Q4 2024.